C Mougin
Overview
Explore the profile of C Mougin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Debernardi A, Jarassier W, Soret C, Mougin C, Alizon S, Bravo I, et al.
Arch Virol
. 2021 Oct;
166(12):3421-3425.
PMID: 34618227
Simple and standardized approaches for genome analysis of human papillomavirus (HPV) by next-generation sequencing are needed. The aim of the study was to develop a protocol for direct deep sequencing...
2.
Bretagne C, Jooste V, Guenat D, Riethmuller D, Bouvier A, Bedgedjian I, et al.
J Gynecol Obstet Hum Reprod
. 2018 May;
47(10):525-531.
PMID: 29807205
Background: Despite the availability of safe and effective HPV vaccines in France, more than 80% of girls remain unvaccinated. Setting: A regional university hospital referral center in France. Objective: To...
3.
Guenat D, Riethmuller D, Ramanah R, Morel A, Aubin F, Mougin C, et al.
J Gynecol Obstet Biol Reprod (Paris)
. 2016 Oct;
45(9):1009-1019.
PMID: 27771203
Prescription of an HPV test in practice will enable the clinician to optimize the monitoring and the management of patients, especially in the context of cervical cancer screening. Numerous HPV...
4.
Bouvret P, Mougin C, Pretet J, Meurisse A, Bonnetain F, Fiteni F
J Gynecol Obstet Biol Reprod (Paris)
. 2016 Jan;
45(8):972-978.
PMID: 26780841
Objectives: To assess opinions, practices and difficulties of general practitioners (GP) of Besançon concerning human papillomavirus (HPV) vaccination. Materials And Methods: A survey among the 140 GP of Besançon, France,...
5.
Martin M, Mougin C, Pretet J, Gil H, Meaux-Ruault N, Puzenat E, et al.
Clin Exp Rheumatol
. 2014 Aug;
32(6 Suppl 86):S-145-8.
PMID: 25151849
Objectives: High risk human papilloma-viruses (HR HPV) are associated with risk of cervical dysplasia and carcinoma. The risk is increased in patients with immune deficiency or auto-immune disease as systemic...
6.
Bellaud G, Gheit T, Pugin A, Pretet J, Tommasino M, Mougin C, et al.
J Eur Acad Dermatol Venereol
. 2014 Mar;
29(5):1019-21.
PMID: 24597770
No abstract available.
7.
Bellaud G, Gheit T, Pugin A, Pretet J, Tommasino M, Mougin C, et al.
J Eur Acad Dermatol Venereol
. 2013 Nov;
28(12):1816-20.
PMID: 24206262
Background: Tumour necrosis factor alpha (TNF-α) inhibitors are associated with an increased risk of infections and with a still debatable risk of skin cancer. Furthermore, cutaneous human papillomavirus (HPV) infection...
8.
Riethmuller D, Pretet J, Denis F, Aubin F, Pradat P, Clavel C, et al.
J Gynecol Obstet Biol Reprod (Paris)
. 2009 Jun;
38(5):389-95.
PMID: 19481365
Objective: To assess the expected impact in France of a quadrivalent HPV 6/11/16/18 vaccine on the occurrence of genital HPV-induced lesions in women. Methods: A Markov model based on a...
9.
Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne J, Dupin N, et al.
Br J Dermatol
. 2009 May;
161(4):904-9.
PMID: 19466962
Background: Human immunodeficiency virus (HIV)+ patients have an increased risk of anogenital warts. High-risk (HR) human papillomaviruses (HPVs), especially types 16 and 18, are major risk factors for precancerous and...
10.
Cajthaml T, Erbanova P, Kollmann A, Novotny C, Sasek V, Mougin C
Folia Microbiol (Praha)
. 2008 Sep;
53(4):289-94.
PMID: 18759111
The ligninolytic fungus Irpex lacteus was shown as an efficient degrader of oligocyclic aromatic hydrocarbons (PAHs; 'polycyclic aromatic hydrocarbons') possessing 3-6 aromatic rings in complex liquid media. The strain produced...